Established in 2014, the Norton Healthcare infectious diseases pharmacy residency provides broad experience in antimicrobial stewardship and infectious diseases. Postgraduate year two (PGY2) residency programs build upon Doctor of Pharmacy (PharmD) education and postgraduate year one (PGY1) pharmacy residency training to develop pharmacist practitioners with knowledge, skills and abilities as defined in the educational competency areas, goals and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.
Norton Healthcare employs eight (seven for adult patients, one for pediatric patients) full-time infectious diseases pharmacists. The system has an established, multidisciplinary antimicrobial stewardship program with a mission to optimize clinical outcomes while minimizing adverse consequences of antimicrobial use — including toxicity, the selection of pathogenic organisms and the emergence of resistance — and to reduce health care costs without adversely impacting quality of care. The antimicrobial stewardship program and its members have been recognized nationally, including with the 2018 Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy Award and the 2023 Gita Patel Best Practice Award from the Society of Infectious Diseases Pharmacists, and a 2019 Best Practices Award from the American Society of Health-System Pharmacists (ASHP).
Norton Healthcare has the largest clinical microbiology laboratory in Kentucky, processing specimens from inpatients and outpatients. It is supported with numerous rapid diagnostic technologies, trained technical staff and a microbiologist with a doctoral degree. Norton Healthcare is a training site for surrounding pharmacy schools, and PGY2 residents will gain teaching experience by serving as co-preceptors for pharmacy students and PGY1 residents.
Norton Infectious Diseases Institute is home to KASIC: Kentucky Antimicrobial Stewardship Innovation Consortium, a statewide antimicrobial stewardship initiative aimed at addressing inequalities in access to antimicrobial stewardship resources. Within the institute, residents have the opportunity to learn from and collaborate with advanced infectious diseases research specialists with expertise in the field of clinical epidemiology.
In 2023, Norton Healthcare’s antimicrobial stewardship program was recognized as a global center of excellence by the British Society of Antimicrobial Chemotherapy Global Antimicrobial Stewardship Accreditation Scheme. The Norton Healthcare program received a Level 3 accreditation, which is the highest level awarded, and it is the first center of excellence in the United States. This designation acknowledges the excellent work done by the antimicrobial stewardship program here and outside the organization, positioning the program as part of a larger conversation worldwide about antimicrobial resistance.
New rotations can be created and existing rotations can be adjusted based on the needs of the resident.
Required Longitudinal Experiences:
Ashley Wilde, Pharm.D., BCIDP
Ashley is the director of infectious diseases clinical programs and research at Norton Healthcare in Louisville, Kentucky. She serves as director of the system antimicrobial stewardship program and is the residency program director for the infectious diseases PGY2 residency. Ashley currently serves as the lead for KASIC: Kentucky Antimicrobial Stewardship Innovation Consortium, a statewide collaboration designed to address inequities in access to antimicrobial stewardship expertise across the commonwealth of Kentucky.
Ashley received her Doctor of Pharmacy degree from Purdue University in West Lafayette, Indiana, and completed PGY1 and PGY2 infectious diseases residency training at Hartford Hospital in Connecticut. She joined Norton Healthcare in 2011 as a clinical pharmacy specialist in infectious diseases.
Ashley is the recipient of the 2018 Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy Award and the 2023 Gita Patel Best Practice Award from the Society of Infectious Diseases Pharmacists. Her areas of interest include innovative models for antimicrobial stewardship and outcomes research. In her free time, she enjoys spending time with her family, spending time outdoors and calligraphy.
Lindsay Jackson, Pharm.D., MBA, BCACP
Lindsay is an ambulatory clinical pharmacy specialist with Norton Infectious Diseases Institute. She graduated from the University of Kentucky with her Doctor of Pharmacy and Master of Business Administration degrees in 2019. She completed PGY1 and PGY2 ambulatory care residencies at Norton Healthcare. Serving both of Norton Healthcare’s ambulatory infectious diseases clinics, she focuses on patients with HIV or hepatitis C, and managing chronic conditions in patients with infectious diseases. Outside of pharmacy, she loves traveling, trying new restaurants and anything outdoors with friends and family.
Wes Johnson, Pharm.D., MPH
Wes is a clinical pharmacy specialist in infectious diseases at Norton Audubon Hospital. He received his Doctor of Pharmacy and Master of Public Health degrees from the University of Kentucky in Lexington. He completed his PGY1 and PGY2 in infectious diseases training at UK HealthCare. His areas of interest include antimicrobial resistance, clinical microbiology and stewardship in the emergency department.
Alan Junkins, Ph.D., D(ABMM)
Alan received his Bachelor of Science in microbiology at Louisiana State University, Baton Rouge, and then earned a doctorate at the University of Wisconsin-Madison. His area of research was on mechanisms of intestinal colonization by E. coli O157:H7. Alan then spent 16 years teaching clinical microbiology to laboratory sciences students at the Medical University of South Carolina in Charleston and the University of Iowa in Iowa City. He went on to complete a two-year fellowship in medical and public health microbiology at the University of Iowa Hospitals & Clinics. He has been chief of microbiology at Norton Healthcare since 2009. Alan precepts a clinical microbiology rotation for the infectious diseases PGY2 resident. His main interests are appropriate use of laboratory tests and optimizing reporting of bacterial identification and susceptibility results.
Jamison Montes de Oca, Pharm.D.
Jamison is a clinical pharmacy specialist in infectious diseases at Norton Hospital. He received a bachelor’s degree in molecular biology from Baker University in Baldwin City, Kansas, before receiving his Doctor of Pharmacy degree from the University of Kansas in Lawrence. He completed his PGY1 and PGY2 infectious diseases pharmacy residency at Henry Ford Hospital in Detroit, Michigan. His areas of interest include gram-negative resistance, transplant infectious diseases and opportunistic infections. Outside of work, he enjoys craft beer, cooking and basketball, and is a novice snowboarder.
Sarah Moore, Pharm.D., BCIDP
Sarah is a clinical pharmacy specialist in infectious diseases at Norton Audubon Hospital. She completed her doctorate in pharmacy at Butler University in Indianapolis, Indiana. She completed both PGY1 and PGY2 at Franciscan Health Indianapolis. Her areas of passion within infectious diseases pharmacy include pharmacokinetics/pharmacodynamics, stewardship, debating primary literature and clinical education. Outside the hospital, she loves hiking, baking and watching soccer.
Paul S. Schulz, M.D.
Dr. Schulz received his Bachelor of Science in chemical engineering at University of Cincinnati, Ohio, and his medical degree from the University of Louisville. He continued on with the University of Louisville School of Medicine to complete an internal medicine residency and infectious diseases fellowship and remained on faculty until 2007 when he joined a private practice group. In 2010, Dr. Schulz joined Norton Healthcare and currently serves as the system epidemiologist participating in antimicrobial stewardship, infection prevention and employee health.
Matthew Song, Pharm.D., BCIDP
Matthew has been a clinical pharmacy specialist in infectious diseases at Norton Healthcare since 2017. Additionally, he serves as co-lead for KASIC. Matthew received a bachelor’s degree in biomedical sciences from Auburn University, Alabama, in 2011 and a doctorate in pharmacy from Auburn University Harrison College of Pharmacy in 2015. He completed a PGY1 pharmacy residency at St. Joseph Hospital in Milwaukee, Wisconsin, and a PGY2 infectious diseases pharmacy residency at Norton Healthcare. Matthew serves as a preceptor to Norton Healthcare pharmacy residents, University of Kentucky pharmacy students and University of Kentucky Doctor of Nursing Practice students. His interests include antimicrobial stewardship, antimicrobial resistance and implementation science. Outside of work, he enjoys cooking, traveling, Auburn University sports, fantasy football and spending time with friends and family.
James “Drew” Stahl, Pharm.D.
Drew is a clinical pharmacy specialist at Norton Children’s Hospital and is responsible for the pediatric antimicrobial stewardship program. Drew received his Doctor of Pharmacy degree from the University of Arkansas for Medical Sciences in Little Rock with honors in research in 2015. His research involved various publications in the field of microbiology/virology. After pharmacy school, Drew pursued a fellowship in pediatric infectious diseases and antimicrobial stewardship at Arkansas Children’s Hospital in Little Rock. His interests include pharmacoeconomics, microbiology methods, penicillin allergy stewardship and clinical research design.
Elena Swingler, Pharm.D., MBA, BCIDP
Elena is a clinical pharmacy specialist in infectious diseases at Norton Women’s & Children’s Hospital. She graduated from Drake University in Des Moines, Iowa, with Doctor of Pharmacy and Master of Business Administration degrees. She then completed both PGY1 and PGY2 residency training at Aurora St. Luke’s Medical Center in Milwaukee, Wisconsin. Her main professional areas of interests include implementing and evaluating antimicrobial stewardship interventions, developing system policy and protocols, antimicrobial resistance, and mycobacterial infections. In her free time she enjoys outdoor activities, drawing and playing the piano.
Clover Truong, Pharm.D., BCPS
Clover is a clinical pharmacy specialist in infectious diseases at Norton Brownsboro Hospital. She received her Doctor of Pharmacy from University of Houston College of Pharmacy, in Texas, in 2020. After graduation, she completed her pharmacy practice residency at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona, and a PGY2 in infectious diseases at Jackson Memorial Hospital in Miami, Florida. Her current interests include multidrug-resistant gram-negative bacteria, oral antimicrobial therapy for complicated infections, antimicrobial stewardship and clinical education. In her free time, she enjoys listening to music, traveling and trying new restaurants.
The Norton Healthcare PGY2 Infectious Diseases Pharmacy Residency uses a flipped residency research model. In a flipped model, residents are assigned a project in the first half of the year that already has been Institutional Review Board (IRB)-approved. The residents will complete data collection and draft a manuscript in the first half of the year. In the second half of the year the residents will propose a project, write a protocol and obtain IRB approval for residents in the following class. Using a flipped model allows the residents to become accustomed to the practices and needs of the institution and therefore better equipped at proposing projects that are feasible, correctly scoped and better aligned with organizational needs. The residents will present their first project at the Great Lakes Pharmacy Residents Conference, present a poster at the Kentucky Society of Health-Systems Pharmacists spring meeting or an equivalent meeting, and be highly encouraged to pursue presentation at a national infectious diseases conference (e.g., IDWeek, MAD-ID, etc.) and publication in a peer-reviewed journal.
Dakota Smith, Pharm.D., MSPGx
Manchester University, Indiana, Class of 2022
Areas of Interest: Antimicrobial stewardship, infectious diseases education
PGY1: Norton Healthcare
Project 1: Evaluation of Adherence to a Health System’s Guidelines for Treatment of Community Acquired Pneumonia
Why Norton Healthcare: I chose Norton Healthcare due to the focus on antimicrobial stewardship and being part of a large team of infectious diseases pharmacists that develops innovative approaches to stewardship and patient care.
Madison Clark, Pharm.D.
University of Houston College of Pharmacy, Texas, Class of 2022
PGY1: Presbyterian Healthcare Services, Albuquerque, New Mexico
Project 1: Effect of Rapid Bacteremia Response Program on Outcomes in Patients With ESBL Bacteremia
Why Norton Healthcare: I chose Norton Healthcare because of its innovative and supportive environment. It was made apparent that the preceptors were committed to resident success. I saw that the variety of opportunities the program offers will allow me to develop into a well-rounded infectious diseases pharmacist. I knew that Norton Healthcare would prepare me to be successful in my career.
Martin Brenneman, Pharm.D., BCIDP
Ohio Northern University Raabe College of Pharmacy, Ada
Project 2: Oral Vancomycin Tapers for First-occurrence of Clostridioides difficile Compared to Standard of Care: An Observational Retrospective Match Cohort Study; poster presented at IDWeek 2023
Project 1: Limited Impact of a Nudge Comment in Promoting De-escalation to First-generation Cephalosporins in Urinary Tract Infections; Kentucky Society of Health-Systems Pharmacist Spring 2022 Meeting Best Poster Award, published in Antimicrobial Stewardship & Healthcare Epidemiology
Current role: Clinical pharmacy specialist – infectious diseases/antimicrobial stewardship coordinator, Baptist Health Corbin, Kentucky
Chris Whitman, Pharm.D., BCIDP
Auburn University Harrison College of Pharmacy
PGY1: East Alabama Medical Center, Opelika
Project 2: Limited Impact of a Nudge Comment in Promoting De-escalation to First-generation Cephalosporins in Urinary Tract Infections; published in Antimicrobial Stewardship & Healthcare Epidemiology
Project 1: Antimicrobial Stewardship Meets Transition of Care: Defining the Length of Therapy for Community-acquired Bacterial Pneumonia; published in The University of Louisville Journal of Respiratory Infections
Current role: Antimicrobial stewardship clinical pharmacy coordinator, Infirmary Health, Mobile, Alabama
Nick Tinker, Pharm.D., BCIDP
University of Colorado Skaggs School of Pharmacy, Aurora
PGY1: St. Anthony Hospital, Lakewood, Colorado
Project: Impact of Pharmacist-driven Ordering of First-dose Antibiotics in Patients with Staphylococcus Aureus Bacteremia
Current role: Advanced clinical pharmacist, infectious diseases/antimicrobial stewardship pharmacist, Intermountain Healthcare, Murray, Utah
PGY1: Saint Joseph Hospital, Milwaukee, Wisconsin
Project: Opt Out Approach to Antimicrobial Stewardship Using Personalized Custom Electronic Alert Recommendations at a Community Hospital; poster presented at IDWeek 2018
Current role: Clinical pharmacy specialist, infectious diseases, Norton Healthcare; and co-lead, Kentucky Antimicrobial Stewardship Innovation Consortium
Shaina Doyen, Pharm.D., BCIDP
Sullivan University College of Pharmacy and Health Sciences, Louisville
PGY1: UofL Health
Project: Impact of 2010 Cephalosporin CLSI Breakpoint Revisions for Enterobacteriaceae on Susceptibility and Antibiotic Utilization; poster presented at Microbe 2016; Kentucky Society of Health-Systems Pharmacists 2016 Spring Meeting Best Poster Award
Current role: Manager, antimicrobial stewardship and co-chair, antimicrobial stewardship system committee, Baptist Health System, Louisville
Nick Hudson, Pharm.D., BCIDP
Pharmacy school: University of Cincinnati James L. Winkle College of Pharmacy, Ohio
PGY1: Baptist Health Lexington, Kentucky
Project: Determining the Risk of Antimicrobial Resistance in Common Gram-positive and Gram-negative Pathogens Following Antibiotic Exposure; poster presented at IDWeek 2015
Current role: Infectious diseases clinical pharmacist, Elkhart General Hospital, Indiana
All application materials must be submitted via the Pharmacy Online Residency Centralized Application Service (PhORCAS). There are no additional application materials required beyond PhORCAS requirements. No material, including letters of recommendation, will be accepted via U.S. mail, email or by submission in person.
The candidate must have completed an ASHP-accredited PGY1 program or one in the accreditation process. A copy of the PGY1 residency certificate must be provided on or before the first day of starting the PGY2 residency program. All applicants must be eligible for licensure in the state of Kentucky.
Salary and Benefits
The PGY2 resident is eligible for full employee benefits of Norton Healthcare. Each PGY2 resident is salaried and receives a stipend of $56,160 plus benefits. Each position requires a one-calendar-year commitment.
Benefits at a Glance
For additional information, contact:
Ashley Wilde, Pharm.D., BCIDPDirector, Infectious Diseases Clinical Programs and ResearchResidency Program Director, PGY2 Infectious DiseasesKentucky Antimicrobial Stewardship Innovation Consortium Lead
Norton Infectious Diseases InstituteNorton Medical Plaza I – Brownsboro, Suite 3034950 Norton Healthcare Blvd.Louisville, KY 40241
Sarah Moore, Pharm.D., BCIDPClinical Pharmacy Specialist – Infectious DiseasesResidency Program Coordinator, PGY2 Infectious Diseases
Select an appointment date and time from available spots listed below.